ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 41 filers reported holding ADC THERAPEUTICS SA in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,488 | -58.3% | 19,496 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $41,916 | +10.3% | 19,496 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $38,017 | -49.2% | 19,496 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $74,865 | -20.4% | 19,496 | -0.0% | 0.00% | -50.0% |
| Q3 2022 | $94,000 | -39.4% | 19,502 | +0.0% | 0.00% | -20.0% |
| Q2 2022 | $155,000 | -45.8% | 19,497 | +0.1% | 0.01% | -54.5% |
| Q1 2022 | $286,000 | -27.4% | 19,469 | -0.2% | 0.01% | -31.2% |
| Q4 2021 | $394,000 | -25.7% | 19,505 | -0.0% | 0.02% | -33.3% |
| Q3 2021 | $530,000 | +11.6% | 19,514 | +0.0% | 0.02% | +9.1% |
| Q2 2021 | $475,000 | -0.2% | 19,507 | +0.0% | 0.02% | -12.0% |
| Q1 2021 | $476,000 | – | 19,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $5,718,000 | 3.34% |
| Blue Owl Capital Holdings LP | 733,568 | $3,536,000 | 1.53% |
| Redmile Group, LLC | 7,512,029 | $36,208,000 | 1.40% |
| GCM Grosvenor Holdings, LLC | 735,471 | $3,545,000 | 0.84% |
| Prosight Management, LP | 247,630 | $1,194,000 | 0.64% |
| Indie Asset Partners, LLC | 93,839 | $452,000 | 0.46% |
| MPM BioImpact LLC | 334,384 | $1,612,000 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,390,297 | $11,521,000 | 0.23% |
| Eventide Asset Management | 1,879,959 | $9,061,000 | 0.18% |
| APOGEM CAPITAL LLC | 17,405 | $84,000 | 0.08% |